SBE13 Hydrochloride

Overview

SBE13 Hydrochloride is a potent and selective Plk1 inhibitor, with an IC 50 of 200 pM; SBE13 Hydrochloride poorly inhibits Plk2 (IC 50 >66 μM) or Plk3 (IC 50 =875 nM).

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Polo-like Kinase (PLK) | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-15158
• CAS No.: 1052532-15-6
• Molecular Formula: C24H28Cl2N2O4
• Molecular Weight: 479.40
• Purity: 98.56%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (5.21 mM); Clear solution
• Availability: In-stock

Source

Original product source